Endocarditis and myocarditis: a brief review

References

• Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect. Dis. 11, 48 (2011).
   PubMed Web of Science ®Google Scholar
• Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native-valve endocarditis in adults: risk classification for mortality. JAMA 289(15), 1933–1940 (2003).
   PubMed Web of Science ®Google Scholar
• Vanassche T, Peetermans WE, Herregods MC, Herijgers P, Verhamme P. Anti-thrombotic therapy in infective endocarditis. Expert Rev. Cardiovasc. Ther. 9(9), 1203–1219 (2011).
   PubMedGoogle Scholar
• Rodbard S. Blood velocity and endocarditis. Circulation 27, 18–28 (1963).
   PubMed Web of Science ®Google Scholar
• Contrepois A. Towards a history of infective endocarditis. Med. Hist. 40(1), 25–54 (1996).
   PubMed Web of Science ®Google Scholar
• Osler W. The Gulstonian lectures, on malignant endocarditis. Br. Med. J. 1(1264), 577–579 (1885).
   PubMedGoogle Scholar
• Dillon JC, Feigenbaum H, Konecke LL, Davis RH, Chang S. Echocardiographic manifestations of valvular vegetations. Am. Heart J. 86(5), 698–704 (1973).
   PubMed Web of Science ®Google Scholar
• Que YA, Moreillon P. Infective endocarditis. Nat. Rev. Cardiol. 8(6), 322–336 (2011).
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Calderwood SB. Infective endocarditis in adults. N. Engl. J. Med. 345(18), 1318–1330 (2001).
   PubMed Web of Science ®Google Scholar
• Prendergast BD. Diagnostic criteria and problems in infective endocarditis. Heart 90(6), 611–613 (2004).
   PubMedGoogle Scholar
• Berbari EF, Cockerill FR 3rd, Steckelberg JM. Infective endocarditis due to unusual or fastidious micro-organisms. Mayo Clin. Proc. 72(6), 532–542 (1997).
   PubMed Web of Science ®Google Scholar
• Asopa S, Patel A, Khan OA, Sharma R, Ohri SK. Non-bacterial thrombotic endocarditis. Eur. J. Cardiothorac. Surg. 32(5), 696–701 (2007).
   PubMedGoogle Scholar
• Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am. Heart J. 113(3), 773–784 (1987).
   PubMed Web of Science ®Google Scholar
• Salem DN, O’Gara PT, Madias C, Pauker SG; American College of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(Suppl. 6), 593S–629S (2008).
   Web of Science ®Google Scholar
• Tleyjeh IM, Steckelberg JM, Murad HS et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293(24), 3022–3028 (2005).
   PubMed Web of Science ®Google Scholar
• Carapetis JR. Rheumatic heart disease in developing countries. N. Engl. J. Med. 357(5), 439–441 (2007).
   PubMed Web of Science ®Google Scholar
• Hoen B, Alla F, Selton-Suty C et al.; Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288(1), 75–81 (2002).
   PubMed Web of Science ®Google Scholar
• Cabell CH, Abrutyn E, Fowler VG Jr et al.; International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators. Use of surgery in patients with native-valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am. Heart J. 150(5), 1092–1098 (2005).
   PubMedGoogle Scholar
• Murdoch DR, Corey GR, Hoen B et al.; International Collaboration on Endocarditis–Prospective Cohort Study (ICE–PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch. Intern. Med. 169(5), 463–473 (2009).
   PubMed Web of Science ®Google Scholar
• Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 96(3), 200–209 (1994).
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS et al.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23), e394–e434 (2005).
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P et al.; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur. Heart J. 30(19), 2369–2413 (2009).
   PubMed Web of Science ®Google Scholar
• Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J. Am. Coll. Cardiol. 18(2), 391–397 (1991).
   PubMed Web of Science ®Google Scholar
• Yusuf SW, Ali SS, Swafford J et al. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994–2004. Medicine (Baltimore). 85(2), 86–94 (2006).
   PubMedGoogle Scholar
• Banchs J, Yusuf SW. Echocardiographic evaluation of cardiac infections. Expert Rev. Cardiovasc. Ther. 10(1), 1–4 (2012).
   PubMedGoogle Scholar
• Naqvi TZ, Rafie R, Ghalichi M. Real-time 3D TEE for the diagnosis of right-sided endocarditis in patients with prosthetic devices. JACC. Cardiovasc. Imaging 3(3), 325–327 (2010).
   PubMedGoogle Scholar
• Horstkotte D, Follath F, Gutschik E et al.; Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur. Heart J. 25(3), 267–276 (2004).
   PubMed Web of Science ®Google Scholar
• Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur. Heart J. 28(2), 196–203 (2007).
   PubMed Web of Science ®Google Scholar
• Delay D, Pellerin M, Carrier M et al. Immediate and long-term results of valve replacement for native and prosthetic-valve endocarditis. Ann. Thorac. Surg. 70(4), 1219–1223 (2000).
   PubMedGoogle Scholar
• David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J. Thorac. Cardiovasc. Surg. 133(1), 144–149 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116(15), 1736–1754 (2007).
   PubMed Web of Science ®Google Scholar
• Aretz HT, Billingham ME, Edwards WD et al. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1(1), 3–14 (1987).
   PubMedGoogle Scholar
• Maisch B, Portig I, Ristic A, Hufnagel G, Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 25(3), 200–209 (2000).
   PubMed Web of Science ®Google Scholar
• Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93(5), 841–842 (1996).
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Wagner A, Deluigi CC et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15), 1581–1590 (2006).
   PubMed Web of Science ®Google Scholar
• Kindermann I, Barth C, Mahfoud F et al. Update on myocarditis. J. Am. Coll. Cardiol. 59(9), 779–792 (2012).
   PubMed Web of Science ®Google Scholar
• Bowles NE, Ni J, Kearney DL et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 42(3), 466–472 (2003).
   PubMed Web of Science ®Google Scholar
• Frustaci A, Cuoco L, Chimenti C et al. Celiac disease associated with autoimmune myocarditis. Circulation 105(22), 2611–2618 (2002).
   PubMed Web of Science ®Google Scholar
• Burke AP, Saenger J, Mullick F, Virmani R. Hypersensitivity myocarditis. Arch. Pathol. Lab. Med. 115(8), 764–769 (1991).
   PubMed Web of Science ®Google Scholar
• Maekawa Y, Ouzounian M, Opavsky MA, Liu PP. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1), 5–8 (2007).
   PubMed Web of Science ®Google Scholar
• Sarda L, Colin P, Boccara F et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J. Am. Coll. Cardiol. 37(3), 786–792 (2001).
   PubMedGoogle Scholar
• Theleman KP, Kuiper JJ, Roberts WC. Acute myocarditis (predominately lymphocytic) causing sudden death without heart failure. Am. J. Cardiol. 88(9), 1078–1083 (2001).
   PubMed Web of Science ®Google Scholar
• Lieberman EB, Herskowitz A, Rose NR, Baughman KL. A clinicopathologic description of myocarditis. Clin. Immunol. Immunopathol. 68(2), 191–196 (1993).
   PubMedGoogle Scholar
• Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 379(9817), 738–747 (2012).
   PubMed Web of Science ®Google Scholar
• Nakashima H, Katayama T, Ishizaki M, Takeno M, Honda Y, Yano K. Q wave and non-Q wave myocarditis with special reference to clinical significance. Jpn. Heart J. 39(6), 763–774 (1998).
   PubMedGoogle Scholar
• Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur. J. Heart Fail. 13(4), 398–405 (2011).
   PubMed Web of Science ®Google Scholar
• Mendes LA, Picard MH, Dec GW, Hartz VL, Palacios IF, Davidoff R. Ventricular remodeling in active myocarditis. Myocarditis Treatment Trial. Am. Heart J. 138(2 Pt 1), 303–308 (1999).
   PubMedGoogle Scholar
• Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart 92(7), 987–993 (2006).
   PubMed Web of Science ®Google Scholar
• Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95(1), 163–168 (1997).
   PubMed Web of Science ®Google Scholar
• Lauer B, Niederau C, Kühl U et al. Cardiac troponin T in patients with clinically suspected myocarditis. J. Am. Coll. Cardiol. 30(5), 1354–1359 (1997).
   PubMed Web of Science ®Google Scholar
• Abdel-Aty H, Boyé P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J. Am. Coll. Cardiol. 45(11), 1815–1822 (2005).
   PubMed Web of Science ®Google Scholar
• Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246(2), 401–409 (2008).
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM et al.; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116(19), 2216–2233 (2007).
   PubMed Web of Science ®Google Scholar
• Lindenfeld J, Albert NM, Boehmer JP et al.; Heart Failure Society of America. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J. Card. Fail. 16(6), e1–e194 (2010).
   Web of Science ®Google Scholar
• Olsen EG. The value of endomyocardial biopsies in myocarditis and dilated cardiomyopathy. Eur. Heart J. 12(Suppl. D), 10–12 (1991).
   PubMedGoogle Scholar
• Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin. Proc. 64(10), 1235–1245 (1989).
   PubMed Web of Science ®Google Scholar
• Mason JW, O’Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 333(5), 269–275 (1995).
   PubMed Web of Science ®Google Scholar
• Kindermann I, Kindermann M, Kandolf R et al. Predictors of outcome in patients with suspected myocarditis. Circulation 118(6), 639–648 (2008).
   PubMed Web of Science ®Google Scholar
• Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113(4), 593–595 (2006).
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J et al.; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J. Am. Coll. Cardiol. 53(17), 1475–1487 (2009).
   PubMed Web of Science ®Google Scholar
• Kishimoto C, Crumpacker CS, Abelmann WH. Ribavirin treatment of murine Coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. J. Am. Coll. Cardiol. 12(5), 1334–1341 (1988).
   PubMed Web of Science ®Google Scholar
• Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant α interferon on Coxsackievirus B3 myocarditis in mice. Am. Heart J. 115(6), 1229–1232 (1988).
   PubMedGoogle Scholar
• Lenzo JC, Shellam GR, Lawson CM. Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrob. Agents Chemother. 45(5), 1444–1449 (2001).
   PubMed Web of Science ®Google Scholar
• McNamara DM, Rosenblum WD, Janosko KM et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95(11), 2476–2478 (1997).
   PubMed Web of Science ®Google Scholar
• Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104(1), 39–45 (2001).
   PubMed Web of Science ®Google Scholar
• Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur. Heart J. 30(16), 1995–2002 (2009).
   PubMed Web of Science ®Google Scholar
• Miric M, Vasiljevic J, Bojic M, Popovic Z, Keserovic N, Pesic M. Long-term follow-up of patients with dilated heart muscle disease treated with human leucocytic interferon α or thymic hormones initial results. Heart 75(6), 596–601 (1996).
   PubMed Web of Science ®Google Scholar
• Kühl U, Pauschinger M, Schwimmbeck PL et al. Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22), 2793–2798 (2003).
   PubMed Web of Science ®Google Scholar
• Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N. Engl. J. Med. 336(26), 1860–1866 (1997).
   PubMed Web of Science ®Google Scholar
• McNamara DM, Holubkov R, Starling RC et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103(18), 2254–2259 (2001).
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Mason JW. Diagnosing and treating active myocarditis. West. J. Med. 150(4), 431–435 (1989).
   PubMedGoogle Scholar